variables | RR group (n = 8) | non-RR group (n = 9) | P value |
---|---|---|---|
Age | 46.1 ± 14.3 | 47.1 ± 9.4 | 0.87 |
Male Sex, n | 6 | 8 | 0.45 |
Disease duration (months) | 36.1 ± 65.5 | 79.0 ± 46.5 | 0.14 |
Height (cm) | 165 ± 9 | 168 ± 5 | 0.35 |
Weight (kg) | 64.1 ± 12.5 | 67.2 ± 9.4 | 0.56 |
BMI | 23.4 ± 3.9 | 23.8 ± 3.2 | 0.83 |
HR (bpm) | 90 ± 23 | 84 ± 20 | 0.63 |
Method of biopsy (transcatheter /surgery) | 4/4 | 0/9 | 0.019 |
Treatment | |||
 Beta-blocker, n | 7 | 8 | 0.93 |
 ACEI or ARB, n | 6 | 8 | 0.45 |
 Inotropes, n | 2 | 8 | 0.008 |
 IABP, n | 0 | 2 | 0.16 |
 AVR, n | 2 | 1 | 0.45 |
 VAD implantation, n | 2 | 8 | 0.008 |
Labo data | |||
 Hb (g/dL) | 12.8 ± 2.3 | 11.4 ± 1.7 | 0.17 |
 T-Bil (mg/dl) | 1.1 ± 0.3 | 1.2 ± 0.8 | 0.70 |
 Cre (mg/dl) | 0.92 ± 0.36 | 1.40 ± 0.45 | 0.029 |
 BNP (pg/ml) | 725 ± 454 | 475 ± 177 | 0.15 |
Echocardiogram | |||
 LVDD (mm) | 72 ± 10 | 79 ± 12 | 0.19 |
 LVDS (mm) | 65 ± 8 | 72 ± 12 | 0.20 |
 LVEF (%) | 21.5 ± 5.1 | 20.4 ± 4.2 | 0.63 |
 LAD (mm) | 50 ± 9 | 54 ± 11 | 0.43 |
 AR (moderate to severe, n) | 2 | 1 | 0.45 |
 MR (moderate to severe, n) | 6 | 6 | 0.71 |
 TR (moderate to severe, n) | 2 | 3 | 0.71 |
Hemodynamics | |||
 PAP, mean (mmHg) | 36 ± 10 | 38 ± 10 | 0.60 |
 PCWP, mean (mmHg) | 27 ± 6 | 29 ± 9 | 0.57 |
 RAP, mean (mmHg) | 10 ± 2 | 13 ± 6 | 0.16 |
 CO (L/min) | 4.02 ± 0.68 | 3.79 ± 0.90 | 0.56 |
 CI (L/min/m2) | 2.30 ± 0.34 | 2.06 ± 0.47 | 0.25 |
 PVR (Wood) | 2.41 ± 1.66 | 2.45 ± 1.61 | 0.96 |